Showing results (771-780 of 806) with videos related to

Sort By:
Pageof 81
Research and Practice in Thrombosis and Haemostasis|April 30, 2026
Patterns of presentation of suspected and confirmed recurrent venous thromboembolism in patients with prior venous thromboembolismVicky Mai, Emily S L Martens, Marc Righini, et al.
Cell Stem Cell|November 3, 2018
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapyJoanne I Hsu, Tajhal Dayaram, Ayala Tovy, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factorC Kearon, J S Ginsberg, D R Anderson, et al.
Alcohol (Fayetteville, N.Y.)|June 6, 2022
New insights into the mechanism of alcohol-mediated organ damage via its impact on immunity, metabolism, and repair pathways: A summary of the 2021 Alcohol and Immunology Research Interest Group (AIRIG) meetingShanawaj Khair, Lisa A Brenner, Michael Koval, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 12, 2024
Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1Johanna R Abend, Atul Sathe, Matthias B Wrobel, et al.
Research and Practice in Thrombosis and Haemostasis|June 15, 2026
The diagnostic performance of the YEARS and Pulmonary Embolism Graduated D-dimer algorithms in patients with prior venous thrombosis suspected of pulmonary embolismEmily S L Martens, Vicky Mai, Veronica Bates, et al.
Alcohol (Fayetteville, N.Y.)|April 6, 2024
Emerging concepts in alcohol, infection & immunity: A summary of the 2023 alcohol and immunology research interest group (AIRIG) meetingLauren N Rutt, Mengfei Liu, Esther Melamed, et al.
Alcohol (Fayetteville, N.Y.)|February 15, 2019
Summary of the 2018 Alcohol and Immunology Research Interest Group (AIRIG) meetingPaulius V Kuprys, Hidekazu Tsukamoto, Bin Gao, et al.
Mbio|April 27, 2023
Aging-Associated Augmentation of Gut Microbiome Virulence Capability Drives Sepsis SeverityJames F Colbert, Joshua M Kirsch, Christopher L Erzen, et al.
Blood|January 9, 2013
A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 TrialA Keith Stewart, Suzanne Trudel, Nizar J Bahlis, et al.
Pageof 81